Japan Leads Pledges of $2.4 Billion to Bridge Covax Funding Gap
(Bloomberg) -- Japan's Prime Minister Yoshihide Suga led donations totaling $2.4 billion aimed at closing a funding gap that has hampered the distribution of coronavirus vaccinations to poorer nations around the world.
At a summit on Wednesday co-hosted with Gavi, the vaccine alliance, Suga said Japan will provide an additional $800 million to the World Health Organization-backed Covax initiative that is purchasing vaccines for 92 low-and-middle-income countries.
Almost 40 donor nations, companies and charities -- including Australia, Canada, France, Spain, Switzerland and the Bill & Melinda Gates Foundation -- also promised to make additional financial contributions and provide millions of Covid-19 inoculations.
“There's a need to close the funding gap as soon as possible,” said Toshimitsu Motegi, Japan's foreign minister. Covax's goals “cannot be met by one country alone,” Suga added.
The pledges provide a much needed boost for Covax, which has struggled to supply countries that have been unable to procure their own vaccines after wealthier ones snapped up most of the world's existing shots. That was in part due to export curbs imposed by India, which was meant to be a major provider until it was hit by a brutal wave of infections. Covax has so far only shipped 77 million doses.
Global Rollout
Scientists have said that rolling vaccines out around the world will be key to ending the pandemic, which continues to rage in Asia. Infection numbers are dwindling in the U.S. and other countries whose immunization programs are relatively advanced.
The contributions at the summit exceeded a $1.7 billion target and Covax has now raised a total of $9.6 billion, which will help it distribute a targeted 1.8 billion doses by early 2022 and cover 30% of the population in participating countries.
“Global leaders clearly recognize the need for equitable access and support the principle that ability to pay should not determine whether someone is protected from this virus,” Seth Berkley, the chief executive officer of Gavi, said in a statement.
Along with the donations, the WHO on Tuesday bolstered Covax's toolkit by authorizing the use of the vaccine made by China's Sinovac Biotech Ltd.
Though China's shots have been criticized for their lower efficacy rates, the WHO backing has given additional inoculation options to Covax. Already cleared for emergency use by the WHO are shots from Pfizer Inc. and partner BioNTech SE, AstraZeneca Plc, Johnson & Johnson and Moderna Inc.
Wednesday's summit came as Japan struggled to accelerate its own vaccination program, with about 14 million doses so far given among its 126 million people, less than two month before it hosts the Olympics in Tokyo.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.